Vice President, Head of IP and Strategic Transactions

United Kingdom
Today
Job Type
Permanent
Work Pattern
Full-time
Work Location
On-site
Seniority
Director
Education
Degree
Posted
11 May 2026 (Today)

Your work will change lives. Including your own.

The Impact You’ll Make

Recursion is seeking a Head of Intellectual Property and Strategic Transactions to shape the company’s IP strategy and support high-value business development, licensing, collaboration, and platform transactions. We recognize that intellectual property is core to our remit: advancing a portfolio of differentiated medicines across wholly owned and partnered programs, enabled by an AI-native platform integrating biology, chemistry, and clinical development. The opportunity is vast and crucial, working within the intersection of law, science, and technology to drive the future of therapeutic discovery.

The ideal candidate has deep experience with pharmaceutical patent strategy and complex life sciences transactions and is comfortable operating in a fast-moving, science-driven environment. The successful candidate will collaborate with colleagues on IP protection for chemical matter, platform technology, and other discoveries as well as forming deep partnerships with our Business Development and Alliance Management teams. The role must possess integrity and sound judgment, be an analytical and creative thinker, have exceptional oral and written communication skills, and be proficient in time-management and task prioritization.

In this role, you will:

Patent Strategy & Oversight

  • Develop and lead patent prosecution and enforcement strategy to protect the company’s chemical and technological innovations
  • Oversee global patent portfolio development in pharmaceuticals, including prosecution and coordination with outside counsel
  • Identify emerging IP risks and opportunities in partnership with scientific and business leaders
  • Provide strategic guidance on patentability, freedom to operate, and IP risk to inform R&D and business decisions
  • Interpret evolving IP laws and competitive dynamics to shape portfolio and enforcement strategy

Strategic Transactions

  • Advise on and support complex life sciences transactions, including collaborations, licensing, and other strategic deals
  • Lead negotiation and execution of key agreements in alignment with company objectives
  • Conduct and guide IP diligence for in-licensing and out-licensing activities
  • Ensure IP considerations, risks, and obligations are effectively integrated into transactional strategy
  • Advise internal stakeholders on IP-related risks, compliance, and business implications across partnerships while promoting strong IP practices and innovation awareness

The Team You’ll Join

You will be joining a dynamic team of attorneys, stock administration professionals, and an IP paralegal, who you will manage. The team works closely and collaboratively with one another on overall legal strategy, departmental budget, projects, and professional development. The team relies on a communicative and supportive atmosphere to enable nimble advice and prioritization aligned with business goals.

The Experience You’ll Need

  • 10+ of experience drafting and prosecuting patent applications in the life sciences in the US and internationally at a law firm and in-house, including patent portfolio management
  • Significant experience with supporting strategic transactions, from drafting term sheets to direct negotiations
  • Leadership or managerial experience
  • Deep knowledge of and experience with patent and trade secret laws, particularly in the field of pharmaceuticals and biotechnology
  • Ability to operate independently with scientists and business leaders to create an intellectual property portfolio aligned with company strategy
  • An interest in learning about emerging trends in biotech, including the deployment of artificial intelligence (AI) workflows throughout the drug development life cycle, from target identification through the clinical approval process.
  • Ability to translate and communicate complex subject matter to internal stakeholders, e.g., science to nonscientists and legal materials to nonlawyers
  • Registered to practice at the USPTO
  • Admitted to practice in at least one state and eligible to practice law in Utah as in-house counsel

Working Location & Compensation:

This is an office-based, hybrid position at our US headquarters located inSalt Lake City, Utah. Employees are expected to work in the office at least 50% of the time.

At Recursion, we believe that every employee should be compensated fairly. Based on the skill and level of experience required for this role, the estimated current annual base range for this role is$337,700 to $432,000 (USD). You will also be eligible for an annual bonus and equity compensation, as well as a comprehensive benefits package.

#LI-DB1

#LI-REMOTE

The Values We Hope You Share:

  • We act boldly with integrity.We are unconstrained in our thinking, take calculated risks, and push boundaries, but never at the expense of ethics, science, or trust.
  • We care deeply and engage directly.Caring means holding a deep sense of responsibility and respect - showing up, speaking honestly, and taking action.
  • We learn actively and adapt rapidly.Progress comes from doing. We experiment, test, and refine, embracing iteration over perfection.
  • We move with urgency because patients are waiting.Speed isn’t about rushing but about moving the needle every day.
  • We take ownership and accountability. Through ownership and accountability, we enable trust and autonomy—leaders take accountability for decisive action, and teams own outcomes together.
  • We are One Recursion.True cross-functional collaboration is about trust, clarity, humility, and impact. Through sharing, we can be greater than the sum of our individual capabilities.

Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.

More About Recursion

Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.

Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.

Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.

Accommodations are available on request for candidates taking part in all aspects of the selection process.


Recruitment & Staffing Agencies: Recursion Pharmaceuticals and its affiliate companies do not accept resumes from any source other than candidates. The submission of resumes by recruitment or staffing agencies to Recursion or its employees is strictly prohibited unless contacted directly by Recursion’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Recursion, and Recursion will not owe any referral or other fees. Our team will communicate directly with candidates who are not represented by an agent or intermediary unless otherwise agreed to prior to interviewing for the job.

Related Jobs

View all jobs
Spotlight

Senior Director Global Clinical Program Lead Cardiovascular & Renal

CSL
On-site

Vice President, Real World Evidence (RWE)

Recursion United Kingdom

Director, Neuroscience (In Vitro Cellular Biology)

Recursion United Kingdom
£198,000 – £237,600 pa Hybrid

Associate Director, Regulatory Operations and Intelligence

Recursion North Tyneside, NE29 8EP, United Kingdom

Computational Protein Designer

Latent Labs London, United Kingdom, United Kingdom
Hybrid

Medical Affairs AI Lead

Pfizer United States

Medical Affairs AI Lead

Pfizer London, SW7 2AP, United Kingdom

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

Where to Advertise Biotech Jobs in the UK (2026 Guide)

Advertising biotech jobs in the UK requires a different approach to most technical hiring. The candidate pool spans life scientists, computational biologists, regulatory specialists and biomanufacturing engineers — each with distinct professional networks and job search behaviours. General job boards reach a broad audience but lack the specificity that biotech professionals expect. Specialist platforms, academic channels and sector-specific communities each serve a different part of the market. This guide, published by BiotechnologyJobs.co.uk, covers where to advertise biotech roles in the UK in 2026, how the main platforms compare, what employers should expect to pay, and what the data says about hiring across different role types.

Biotech Jobs UK 2026: What to Expect Over the Next 3 Years

Biotechnology is creating jobs at a rate that few other sectors can match. New disciplines are emerging from research labs and entering commercial hiring pipelines, existing roles are fragmenting into deeper specialisms, and the technologies driving it all — from AI-assisted drug discovery to next-generation gene editing — are advancing faster than the workforce can keep pace with. For job seekers, this creates an unusual challenge. In most industries, career planning means navigating a relatively familiar landscape and identifying where your skills fit. In biotech, that landscape is being actively redrawn. The roles generating the most hiring activity in 2028 may look quite different from the ones appearing in job adverts today. That's not a reason to feel overwhelmed — it's a reason to get informed. The candidates who thrive in this market aren't always those with the longest CVs or the most letters after their name. They're the ones who understand where the sector is heading: which disciplines are gaining commercial traction, which technologies are driving employer demand, and how the definition of a "biotech job" is expanding well beyond traditional pharmaceuticals and research roles. This article breaks down what the UK biotech jobs market is likely to look like over the next three years — covering emerging job titles, the technologies reshaping hiring, the skills employers are prioritising right now, and how to position your career ahead of the curve rather than behind it.

New Biotech Employers to Watch in 2026: UK and Global Companies Transforming Life Sciences Careers

The biotechnology job market in the UK is entering a new phase—one defined by scientific breakthroughs, targeted investment, and a growing pipeline of innovative employers. For professionals browsing BiotechnologyJobs.co.uk, the key question is no longer just which companies exist, but which ones are scaling, hiring, and shaping the future of life sciences. In this article, we explore the new biotech employers to watch in 2026, focusing on UK-based startups, scale-ups, and international firms with a growing UK presence. These organisations have recently secured funding, partnerships, or strategic backing—strong indicators of hiring momentum in the months ahead.